27-nation bloc preparing to roll out booster campaign ahead of feared wave of new cases come winter

Following CDC approval, new 'bivalent' shots -- which are half the original vaccine and half an Omicron-targeted version -- expected to roll out across America

Massachusetts-based firm accuses rival and its partner of copyright infringement, filing suit in both US and German courts

FDA says tweaked Pfizer and Moderna shots to be available as early as September, but urges fourth dose of existing vaccine for eligible adults

US doctor calls BA.5 'hypercontagious' and WHO says pandemic 'nowhere near over' as virus continues to mutate worldwide and cause concern among experts

Israel raced to give extra boosters before most countries in December; research also shows shots cut hospitalization by over 60%; author: ‘They’re lifesavers'

Health Ministry director-general approves Pfizer and Moderna vaccines for age 6 months and up, but rejects panel's guidance to endorse shots for high-risk babies and toddlers

Albert Bourla insists his company's original vaccine is safe for children as young as 6 months, says he's aiming to create vaccine that offers yearlong protection

Pharma firm announces it has 'two very strong' candidates against the coronavirus variant, as US regulators set to weigh whether to offer updated boosters

Approval means roughly 18 million youngsters under 5 in the US are now eligible for the shots; shots are expected to start next week but it's unclear how popular they will be